{"id":"https://openalex.org/W4388633016","doi":"https://doi.org/10.4155/fmc-2023-0130","title":"Discovery of New VEGFR-2 Inhibitors and Apoptosis inducer-based thieno[2,3- d ]pyrimidine","display_name":"Discovery of New VEGFR-2 Inhibitors and Apoptosis inducer-based thieno[2,3- d ]pyrimidine","publication_year":2023,"publication_date":"2023-11-01","ids":{"openalex":"https://openalex.org/W4388633016","doi":"https://doi.org/10.4155/fmc-2023-0130","pmid":"https://pubmed.ncbi.nlm.nih.gov/37955128"},"language":"en","primary_location":{"id":"doi:10.4155/fmc-2023-0130","doi":"https://doi.org/10.4155/fmc-2023-0130","is_oa":false,"landing_page_url":"https://doi.org/10.4155/fmc-2023-0130","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055035301","display_name":"Souad A. El\u2010Metwally","orcid":"https://orcid.org/0000-0002-3040-9283","observed_orcids":["https://orcid.org/0000-0002-3040-9283"]},"institutions":[{"id":"https://openalex.org/I160419504","display_name":"Higher Technological Institute","ror":"https://ror.org/051q8jk17","country_code":"EG","type":"education","lineage":["https://openalex.org/I160419504"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Souad A El-Metwally","raw_affiliation_strings":["Department of Basic Science Higher Technological institute\r          10th of Ramadan City\r          Egypt"],"raw_orcid":"https://orcid.org/0000-0002-3040-9283","affiliations":[{"raw_affiliation_string":"Department of Basic Science Higher Technological institute\r          10th of Ramadan City\r          Egypt","institution_ids":["https://openalex.org/I160419504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048991764","display_name":"Hazem Elkady","orcid":"https://orcid.org/0000-0003-0893-6703","observed_orcids":["https://orcid.org/0000-0003-0893-6703"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Hazem Elkady","raw_affiliation_strings":["Pharmaceutical Medicinal Chemistry & Drug Design Department Faculty of Pharmacy (Boys) Al-Azhar University\r          Cairo\r          11884\r          Egypt"],"raw_orcid":"https://orcid.org/0000-0003-0893-6703","affiliations":[{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department Faculty of Pharmacy (Boys) Al-Azhar University\r          Cairo\r          11884\r          Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mohamed Hagras","orcid":"https://orcid.org/0000-0002-6062-2544","observed_orcids":["https://orcid.org/0000-0002-6062-2544"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Mohamed Hagras","raw_affiliation_strings":["Department of Pharmaceutical Organic Chemistry College of Pharmacy Al-Azhar University\r          Cairo\r          11884\r          Egypt"],"raw_orcid":"https://orcid.org/0000-0002-6062-2544","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Organic Chemistry College of Pharmacy Al-Azhar University\r          Cairo\r          11884\r          Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074335644","display_name":"Eslam B. Elkaeed","orcid":"https://orcid.org/0000-0002-2546-8035","observed_orcids":["https://orcid.org/0000-0002-2546-8035"]},"institutions":[{"id":"https://openalex.org/I4391767729","display_name":"Almaarefa University","ror":"https://ror.org/00s3s5518","country_code":"SA","type":"education","lineage":["https://openalex.org/I4391767729"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Eslam B Elkaeed","raw_affiliation_strings":["Department of Pharmaceutical Sciences College of Pharmacy AlMaarefa University\r          Riyadh\r          13713\r          Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0002-2546-8035","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences College of Pharmacy AlMaarefa University\r          Riyadh\r          13713\r          Saudi Arabia","institution_ids":["https://openalex.org/I4391767729"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028807146","display_name":"Bshra Ali A. Alsfouk","orcid":"https://orcid.org/0000-0001-6489-6035","observed_orcids":["https://orcid.org/0000-0001-6489-6035"]},"institutions":[{"id":"https://openalex.org/I106778892","display_name":"Princess Nourah bint Abdulrahman University","ror":"https://ror.org/05b0cyh02","country_code":"SA","type":"education","lineage":["https://openalex.org/I106778892"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Bshra A Alsfouk","raw_affiliation_strings":["Department of Pharmaceutical Sciences College of Pharmacy Princess Nourah bint Abdulrahman University\r          PO Box 84428\r          Riyadh\r          11671\r          Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0001-6489-6035","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences College of Pharmacy Princess Nourah bint Abdulrahman University\r          PO Box 84428\r          Riyadh\r          11671\r          Saudi Arabia","institution_ids":["https://openalex.org/I106778892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035913177","display_name":"Ahmed Soliman Doghish","orcid":"https://orcid.org/0000-0002-0136-7096","observed_orcids":["https://orcid.org/0000-0002-0136-7096"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210151980","display_name":"Badr University in Cairo","ror":"https://ror.org/04tbvjc27","country_code":"EG","type":"education","lineage":["https://openalex.org/I4210151980"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Ahmed S Doghish","raw_affiliation_strings":["Biochemistry & Molecular Biology Department Faculty of Pharmacy (Boys) Al-Azhar University\r          Nasr City\r          Cairo\r          11231\r          Egypt","Department of Biochemistry Faculty of Pharmacy Badr University in Cairo (BUC)\r          Badr City\r          Cairo\r          11829\r          Egypt"],"raw_orcid":"https://orcid.org/0000-0002-0136-7096","affiliations":[{"raw_affiliation_string":"Biochemistry & Molecular Biology Department Faculty of Pharmacy (Boys) Al-Azhar University\r          Nasr City\r          Cairo\r          11231\r          Egypt","institution_ids":["https://openalex.org/I184834183"]},{"raw_affiliation_string":"Department of Biochemistry Faculty of Pharmacy Badr University in Cairo (BUC)\r          Badr City\r          Cairo\r          11829\r          Egypt","institution_ids":["https://openalex.org/I4210151980"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108143608","display_name":"Ibrahim M. Ibrahim","orcid":"https://orcid.org/0000-0001-7875-7538","observed_orcids":["https://orcid.org/0000-0001-7875-7538"]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Ibrahim M Ibrahim","raw_affiliation_strings":["Biophysics Department Faculty of Science Cairo University\r          Cairo\r          12613\r          Egypt"],"raw_orcid":"https://orcid.org/0000-0001-7875-7538","affiliations":[{"raw_affiliation_string":"Biophysics Department Faculty of Science Cairo University\r          Cairo\r          12613\r          Egypt","institution_ids":["https://openalex.org/I145487455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007786874","display_name":"Mohammed S. Taghour","orcid":"https://orcid.org/0000-0003-0630-709X","observed_orcids":["https://orcid.org/0000-0003-0630-709X"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Mohammed S Taghour","raw_affiliation_strings":["Pharmaceutical Medicinal Chemistry & Drug Design Department Faculty of Pharmacy (Boys) Al-Azhar University\r          Cairo\r          11884\r          Egypt"],"raw_orcid":"https://orcid.org/0000-0003-0630-709X","affiliations":[{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department Faculty of Pharmacy (Boys) Al-Azhar University\r          Cairo\r          11884\r          Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086351593","display_name":"Dalal Z. Husein","orcid":"https://orcid.org/0000-0001-7552-0914","observed_orcids":["https://orcid.org/0000-0001-7552-0914"]},"institutions":[{"id":"https://openalex.org/I4387155039","display_name":"New Valley University","ror":"https://ror.org/04349ry21","country_code":"EG","type":"education","lineage":["https://openalex.org/I4387155039"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Dalal Z Husein","raw_affiliation_strings":["Chemistry Department Faculty of Science New Valley University\r          El-Kharja\r          72511\r          Egypt"],"raw_orcid":"https://orcid.org/0000-0001-7552-0914","affiliations":[{"raw_affiliation_string":"Chemistry Department Faculty of Science New Valley University\r          El-Kharja\r          72511\r          Egypt","institution_ids":["https://openalex.org/I4387155039"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088150567","display_name":"Ahmed M. Metwaly","orcid":"https://orcid.org/0000-0001-8566-1980","observed_orcids":["https://orcid.org/0000-0001-8566-1980"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210101365","display_name":"City of Scientific Research and Technological Applications","ror":"https://ror.org/00pft3n23","country_code":"EG","type":"facility","lineage":["https://openalex.org/I4210101365"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Ahmed M Metwaly","raw_affiliation_strings":["Biopharmaceutical Products Research Department Genetic Engineering & Biotechnology Research Institute City of Scientific Research & Technological Applications (SRTA-City)\r          Alexandria\r          Egypt","Pharmacognosy & Medicinal Plants Department Faculty of Pharmacy (Boys) Al-Azhar University\r          Cairo\r          11884\r          Egypt"],"raw_orcid":"https://orcid.org/0000-0001-8566-1980","affiliations":[{"raw_affiliation_string":"Biopharmaceutical Products Research Department Genetic Engineering & Biotechnology Research Institute City of Scientific Research & Technological Applications (SRTA-City)\r          Alexandria\r          Egypt","institution_ids":["https://openalex.org/I4210101365"]},{"raw_affiliation_string":"Pharmacognosy & Medicinal Plants Department Faculty of Pharmacy (Boys) Al-Azhar University\r          Cairo\r          11884\r          Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020589815","display_name":"Ibrahim H. Eissa","orcid":"https://orcid.org/0000-0002-6955-2263","observed_orcids":["https://orcid.org/0000-0002-6955-2263"]},"institutions":[{"id":"https://openalex.org/I160419504","display_name":"Higher Technological Institute","ror":"https://ror.org/051q8jk17","country_code":"EG","type":"education","lineage":["https://openalex.org/I160419504"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Ibrahim H Eissa","raw_affiliation_strings":["Department of Basic Science Higher Technological institute\r          10th of Ramadan City\r          Egypt"],"raw_orcid":"https://orcid.org/0000-0002-6955-2263","affiliations":[{"raw_affiliation_string":"Department of Basic Science Higher Technological institute\r          10th of Ramadan City\r          Egypt","institution_ids":["https://openalex.org/I160419504"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5793,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.8167238,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"15","issue":"22","first_page":"2065","last_page":"2086"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.012799999676644802,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vegfr-2-inhibitors","display_name":"VEGFR-2 inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/thieno-2-3-d-pyrimidines","display_name":"thieno[2,3-d]pyrimidines","score":0.9570000171661377},{"id":"https://openalex.org/keywords/apoptosis-induction","display_name":"apoptosis induction","score":0.8029999732971191},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.9049999713897705},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.871999979019165},{"id":"https://openalex.org/keywords/s-phase-arrest","display_name":"S phase arrest","score":0.8889999985694885},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.7149999737739563},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/drug-likeness","display_name":"drug-likeness","score":0.8309999704360962}],"concepts":[{"id":"https://openalex.org/C2225953","wikidata":"https://www.wikidata.org/wiki/Q1661899","display_name":"Inducer","level":3,"score":0.7869123816490173},{"id":"https://openalex.org/C2779321679","wikidata":"https://www.wikidata.org/wiki/Q207722","display_name":"Pyrimidine","level":2,"score":0.7719333171844482},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.634483814239502},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6039484739303589},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5442736744880676},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.47302839159965515},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.36870843172073364},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3638148307800293},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3425912857055664},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33228185772895813},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.33123278617858887},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3205871880054474},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07273930311203003}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D040301","descriptor_name":"Vascular Endothelial Growth Factor Receptor-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D040301","descriptor_name":"Vascular Endothelial Growth Factor Receptor-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D056004","descriptor_name":"Molecular Dynamics Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4155/fmc-2023-0130","doi":"https://doi.org/10.4155/fmc-2023-0130","is_oa":false,"landing_page_url":"https://doi.org/10.4155/fmc-2023-0130","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:37955128","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37955128","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2966172420","display_name":null,"funder_award_id":"PNURSP2023R142","funder_id":"https://openalex.org/F4320322484","funder_display_name":"Princess Nourah Bint Abdulrahman University"}],"funders":[{"id":"https://openalex.org/F4320318809","display_name":"AlMaarefa University","ror":"https://ror.org/00s3s5518"},{"id":"https://openalex.org/F4320322484","display_name":"Princess Nourah Bint Abdulrahman University","ror":"https://ror.org/05b0cyh02"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":73,"referenced_works":["https://openalex.org/W1031578623","https://openalex.org/W1416958482","https://openalex.org/W1554198405","https://openalex.org/W1566271574","https://openalex.org/W1663154925","https://openalex.org/W1964596754","https://openalex.org/W1980851109","https://openalex.org/W1982979730","https://openalex.org/W1992905076","https://openalex.org/W1994701350","https://openalex.org/W1997892364","https://openalex.org/W1999845081","https://openalex.org/W2025816743","https://openalex.org/W2033342433","https://openalex.org/W2040503203","https://openalex.org/W2049655823","https://openalex.org/W2071794983","https://openalex.org/W2077218183","https://openalex.org/W2097699101","https://openalex.org/W2107028695","https://openalex.org/W2107762751","https://openalex.org/W2109080255","https://openalex.org/W2114918609","https://openalex.org/W2120064876","https://openalex.org/W2132589721","https://openalex.org/W2148934717","https://openalex.org/W2157079870","https://openalex.org/W2177424368","https://openalex.org/W2206954826","https://openalex.org/W2286340588","https://openalex.org/W2315212700","https://openalex.org/W2405075761","https://openalex.org/W2740059367","https://openalex.org/W2758563481","https://openalex.org/W2803716353","https://openalex.org/W2895791749","https://openalex.org/W2916915826","https://openalex.org/W2920835902","https://openalex.org/W2940507061","https://openalex.org/W2981810096","https://openalex.org/W3008323409","https://openalex.org/W3043934334","https://openalex.org/W3046227393","https://openalex.org/W3099076257","https://openalex.org/W3159182064","https://openalex.org/W3174415140","https://openalex.org/W3187522263","https://openalex.org/W3194882925","https://openalex.org/W3202287440","https://openalex.org/W3203735717","https://openalex.org/W3206811405","https://openalex.org/W4200625470","https://openalex.org/W4224324545","https://openalex.org/W4232686413","https://openalex.org/W4280614161","https://openalex.org/W4284882937","https://openalex.org/W4284892347","https://openalex.org/W4285731877","https://openalex.org/W4286213515","https://openalex.org/W4287218671","https://openalex.org/W4292304418","https://openalex.org/W4293826815","https://openalex.org/W4296807426","https://openalex.org/W4300003640","https://openalex.org/W4308876442","https://openalex.org/W4313880189","https://openalex.org/W4367668366","https://openalex.org/W4378348953","https://openalex.org/W4379768146","https://openalex.org/W4386609665","https://openalex.org/W4386799353","https://openalex.org/W4386869258","https://openalex.org/W4387643359"],"related_works":["https://openalex.org/W4384700288","https://openalex.org/W4408510784","https://openalex.org/W4390636799","https://openalex.org/W4399050455","https://openalex.org/W4378348953","https://openalex.org/W3159182064","https://openalex.org/W2896595935","https://openalex.org/W4385620012","https://openalex.org/W4400451262","https://openalex.org/W7220964238"],"abstract_inverted_index":{"Background:":[0],"VEGFR-2":[1,46],"is":[2],"a":[3],"key":[4],"regulator":[5],"of":[6,15,53,71,107],"cancer":[7],"cell":[8,55],"proliferation,":[9],"migration":[10],"and":[11,28,57,63,75,101],"angiogenesis.":[12],"Aim:":[13],"Development":[14],"thieno[2,3-d]pyrimidine":[16],"derivatives":[17],"as":[18],"potential":[19],"anti-cancer":[20],"agents":[21],"targeting":[22],"VEGFR-2.":[23,85],"Methods:":[24],"Seven":[25],"in":[26,30],"vitro":[27],"nine":[29],"silico":[31],"studies":[32,67],"were":[33],"conducted.":[34],"Results:":[35],"Compound":[36],"10d":[37],"demonstrated":[38],"strong":[39],"anticancer":[40,99,109],"potential,":[41],"boosting":[42],"apoptosis":[43],"based":[44],"on":[45],"inhibition.":[47],"It":[48],"arrested":[49],"the":[50,54,59,69,72,88,105],"S":[51],"phase":[52],"cycle":[56],"upregulated":[58],"apoptotic":[60],"factors.":[61],"Docking":[62],"molecular":[64],"dynamics":[65],"simulation":[66],"confirm":[68],"stability":[70],"VEGFR-2\u201310d":[73],"complex":[74],"suggest":[76],"that":[77],"these":[78],"compounds":[79],"have":[80],"good":[81,98],"binding":[82],"affinities":[83],"to":[84,104],"In":[86],"addition,":[87],"drug-likeness":[89],"was":[90],"confirmed.":[91],"Conclusion:":[92],"Thieno[2,3-d]pyrimidines,":[93],"particularly":[94],"compound":[95],"10d,":[96],"has":[97],"effects":[100],"may":[102],"contribute":[103],"development":[106],"new":[108],"therapies.":[110]},"counts_by_year":[{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-11-14T00:00:00"}